quarter of 2017, company has been investing in equity securities which gains on revaluation of its investments at fair value at ฿ 79 million. However, the Company will continue to adhere security policy to
long-term savings and investments among the public and to support the development of the Thai capital market by mobilizing funds into the Stock Exchange of Thailand (SET), which would in turn reduce
long-term savings and investments among the public and to support the development of the Thai capital market by mobilizing funds into the Stock Exchange of Thailand (SET), which would in turn reduce
long-term savings and investments among the public and to support the development of the Thai capital market by mobilizing funds into the Stock Exchange of Thailand (SET), which would in turn reduce
Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the yearly period at the end of 31st December 2018 as follows. Summary The Company
of profit from investments in associates 33.6 59.2 -25.6 -43.2% Net Profit 215.0 304.8 -89.7 -29.4% Increase (Decrease) The operating result of the Company for Q1 2019/2020 (1 April 2019 to 30 June
profit margin decreased to 25.2% due to the lower revenue base. Share of loss from investments in JVs and Associates was THB 22mn owing to the performance of Master Ad Public Company Limited as its
Public Company Limited’s (the “Company”) Board of Directors Meeting No. 4/2023 held on 11 May 2023 passed a resolution to certify the financial statements and the performance for the three-month period
of Thailand Major Development Public Company Limited (“The Company”) would like to inform total revenues 3,384.22 million baht and net loss 183.91 million baht in the consolidated financial statement
of Thailand Major Development Public Company Limited (“The Company”) would like to inform total revenues 3,375.21 million baht and net loss 183.91 million baht in the consolidated financial statement